Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-06-25
2010-02-09
Nickol, Gary B (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387900, C530S388100, C530S388230, C530S389100, C530S389200, C530S351000
Reexamination Certificate
active
07659375
ABSTRACT:
The invention is directed to purified and isolated novel human IL-1 epsilon polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, the use of such polypeptides and fragmented peptides in cellular and immune reactions and as molecular weight markers, the use of such polypeptides and fragmented peptides as controls for peptide fragmentation, and kits comprising these reagents.
REFERENCES:
patent: 4376110 (1983-03-01), David et al.
patent: 4411993 (1983-10-01), Gillis
patent: 4486530 (1984-12-01), David et al.
patent: 4518584 (1985-05-01), Mark et al.
patent: 4543439 (1985-09-01), Frackelton, Jr. et al.
patent: RE32011 (1985-10-01), Zimmerman et al.
patent: 4546082 (1985-10-01), Kurjan et al.
patent: 4737462 (1988-04-01), Mark et al.
patent: 4902614 (1990-02-01), Wakabayashi et al.
patent: 4965195 (1990-10-01), Namen et al.
patent: 4968607 (1990-11-01), Dower et al.
patent: 5011912 (1991-04-01), Hopp et al.
patent: 5071972 (1991-12-01), Larsen
patent: 5151412 (1992-09-01), Brown
patent: 5248599 (1993-09-01), Sakiyama et al.
patent: 5350683 (1994-09-01), Sims et al.
patent: 5426048 (1995-06-01), Gearing
patent: 5449758 (1995-09-01), Hartley
patent: 5783672 (1998-07-01), Mosley et al.
patent: 6197551 (2001-03-01), Busfield
patent: A-36776 (1981-09-01), None
patent: A-73657 (1983-03-01), None
patent: A-0367566 (1990-05-01), None
patent: 460846 (1991-12-01), None
patent: 324274 (1993-11-01), None
patent: 367566 (1997-05-01), None
patent: 0 855 404 (1998-07-01), None
patent: WO 90/10448 (1990-09-01), None
patent: WO 90/13641 (1990-11-01), None
patent: WO 91/04753 (1991-04-01), None
patent: WO 91/06629 (1991-05-01), None
patent: WO 98/47921 (1998-10-01), None
patent: WO 99/35268 (1999-07-01), None
patent: WO 99/37662 (1999-07-01), None
patent: WO 00/11174 (2000-03-01), None
U.S. Appl. No. 07/701,415, filed May 16, 1991, Sims et al.
Ashkenazi, A., et al., “Protection againist endotoxic shock by a tumor necrosis factor receptor immunoadhesin,” Proc. Natl. Acad. Sci. USA, 1991, 88:10535-10539.
Ashwell, Jonathan D., “The many paths to p38 mitogen-activated protein kinase activation in the immune system,” Nature Reviews, 2006, 6:532-540.
Ausubel, et al., Ed. Board, Current Protocols in Molecular Biology, vol. 2, (John Wiley & Sons, Inc., (1996)), 10.3.1-10.3.12.
Bauer, et al., “A genetic enrichment for mutations constructed by oligoeoxynucleotide-directed mutagenesis,” Gene, 1985, 37:73-81.
Bazan, et al., “A newly defined interleukin-1?” Nature, Feb. 15, 1996, 379:591.
Beier, et al., “Characterization of a regulatory region upstream of the ADR2 locus of S. cerevisiae,” Nature, 1982, 300:23-30.
Berenson, et al., “Autologous Hematopoietic Reconstitution of Lethally Irradiated Dogs using IA-Positive Bone Marrow Cells,” J. of Cellular Biochemistry, 1986, Suppl 10D:239.
Bitter, et al., “Secretion of foreign proteins fromSaccharomyces cerevisiaedirected by a-factor gene fusions,” Proc. Natl. Acad. Sci. USA, 1984, 81:5330-5334.
Blume, et al., “Immature Transformed Rat Islet β-Cells Differentially Express C-Peptides Derived from the Genes Coding for Insulin I . . . ,” Mol. Endocrinology, 1992, 6:299-307.
Bowie et al., “Deciphering the Message in Protein Sequence Tolerance to Amino Acid Substitutions,” JSTOR: Science: New Series, 1990, 247(4948):1306-1310.
Brock, T.D. and Madigan, M.T., Biology of Microorganisms, (Prentice Hall, 6th Ed., Englewood Cliffs, NJ, (1991)), 76-77.
Brock, T.D. and Madigan, M.T., Biology of Microorganisms, (Prentice Hall, 6th Ed., Englewood Cliffs, NJ, (1991)), 300-301.
Brown, et al., “Characterization of Two Morphology Mutants of Autographa Californica Nuclear Polyhedrosis Virus with . . . Inclusion Bodies,” J. Gen. Virol., 1980, 50:309-316.
Byrn et al.,“Biological properties of a CD4 immunoadhesin,” Nature, 1990, 334:667-670.
Chang, et al., “Phenotypic expression inE. coliof a DNA sequence coding for mouse dihydrofolate reductase,” Nature, 1978, 275(19):617-624.
Cleveland, et al., Peptide Mapping by Limited Proteolysis in Sodium Dodecyl Sulfate and Analysis by Gel Electrophoresis, J. of Biol. Chem., 1977, 252:1102-1106.
Colman, et al., “Effects of amino acid sequence changes on antibody-antigen interactions,” Research in Immunology, 1994, 145:33-36.
Colotta et al., “Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Requlated by IL-4,” Science, 1993, 261(5120):472-475.
Cosman, et al., “Cloning, sequence and expression of human interleukin-2 receptor,” Nature, 1984, 312:768-771.
Cosman, et al., “High Level Stable Expression of Human Interleukin-2 Receptors in Mouse Cells . . . Low Affinity Interleukin-2 Binding Sites,” Mol. Immunol., 1986, 23:935-941.
Craik, et al., “Use of Oligonucleotides for Site-Specific Mutagenesis,” BioTechniques, Jan. 1985, 12-19.
Devereux, et al., “A Comprehensive set of sequence analysis programs for the VAX”, Nucl. Acids Res.,1984, 12:387-395.
Eckerskorn, et al., “Identification of mouse brain proteins after two-dimensional electrophoresis and electroblotting . . . ” Electrophoresis, 1988, 9:830-838.
Evans, et al., “Mapping Receptor Binding Sites in Interleukin (IL)-1 Receptor Antagonist and IL-1β by Site-directed Mutagenesis,” J. of Biol. Chem., 1995, 270(19):11477-11483.
Felgner, et al., “Lipofection: A highly efficient, lipid-mediated DNA-tranfection procedure,” Proc. Natl. Acad. Sci. USA, 1987, 84:7413-7417.
Fiers, et al., “Complete nucleotide sequence of SV40 DNA,” Nature, 1978, 273:113-120.
Fleer, et al., “High-level secretion of correctly processed recombinant human interleukin-1β in Kluyveromyces lactis,” 1991, Gene, 107:285-295.
Geysen, et al., “Cognitive Features of Continuous Antigenic Determinants,” J. of Molecular Recognition, 1988, 1(1):32-41.
Gingeras, et al., “Nucleotide Sequences from the Adenovirus-2 Genome,” Journal of Biological Chemistry, 1982, 257:13475-13491.
Gluzman, V., SV40-Transformed Simian Cells Support the Replication of Early SV40 Mutants, Jan. 1981, Cell, 23:175-182.
Goeddel, et al., “Direct expression inEscherichia coliof a DNA sequence coding for human growth hormone,” Nature, 1979, 281:544-548.
Goeddel, et al., “Synthesis of human fibroblast interferon byE. coli,” Nucl. Acids Res., 1980, 8:4057-4074.
Gribskov and Burgess, “Sigma factors fromE. coli,B. subtilis, phage SP01, and phage T4 are homologous proteins,” Nucl.Acids Res., 1986, 14:6745-6763.
Gross, E., “The Cyanogen Bromide Reaction,” Methods in Enzymology, Enzyme Structure, vol. 11, Hirs, C.H.W., ed., (Academic Press, New YorK, (1967)), 11:238-255.
Hara and Miyajima, “Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3),” EMBO J., 1992, 11(5):1875-1884.
Henzel, et al., “Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein . . . ” Proc. Natl. Acad. Sci. USA, 1993, 90:5011-5015.
Hess, et al., “Cooperation of Glycolytic Enzymes,” J. Adv. Enzyme Reg., 1969, 7:149-167.
Hinnen, et al., “Transformation of yeast,” Proc. Natl. Acad. Sci. USA, 1978, 75:1929-1933.
Hitzeman, et al., “Isolation and Cheracterization of the Yeast 3-Phosphoglycerokinase Gene (PGK) by an Immunological Screening . . . ,” J. Biol. Chem., 1980, 255:1207-12080.
Holland, et al., “Isolation and Identification of Yeast Messenger Ribonucleic Acids Coding for Enolace . . . ” Biochemistry, 1978, 17(23):4900-4907.
Hopp, et al., “A short polypeptide marker sequence useful for recombinant protein identification and purification
Sims John E
Smith Dirk E
Hehman Mary K.
Immunex Corporation
Nickol Gary B
Xie Xiaozhen
LandOfFree
Human IL-1 epsilon DNA and polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human IL-1 epsilon DNA and polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human IL-1 epsilon DNA and polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4218113